APA

Furman P. A., Murakami E., Niu C., Lam A. M., Espiritu C., Bansal S., Bao H., Tolstykh T., Micolochick Steuer H., Keilman M., Zennou V., Bourne N., Veselenak R. L., Chang W., Ross B. S., Du J., Otto M. J. & Sofia M. J. (20111109). Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. : Antiviral research.

Chicago

Furman Phillip A, Murakami Eisuke, Niu Congrong, Lam Angela M, Espiritu Christine, Bansal Shalini, Bao Haiying, Tolstykh Tatiana, Micolochick Steuer Holly, Keilman Meg, Zennou Veronique, Bourne Nigel, Veselenak Ronald L, Chang Wonsuk, Ross Bruce S, Du Jinfa, Otto Michael J and Sofia Michael J. 20111109. Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. : Antiviral research.

Harvard

Furman P. A., Murakami E., Niu C., Lam A. M., Espiritu C., Bansal S., Bao H., Tolstykh T., Micolochick Steuer H., Keilman M., Zennou V., Bourne N., Veselenak R. L., Chang W., Ross B. S., Du J., Otto M. J. and Sofia M. J. (20111109). Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. : Antiviral research.

MLA

Furman Phillip A, Murakami Eisuke, Niu Congrong, Lam Angela M, Espiritu Christine, Bansal Shalini, Bao Haiying, Tolstykh Tatiana, Micolochick Steuer Holly, Keilman Meg, Zennou Veronique, Bourne Nigel, Veselenak Ronald L, Chang Wonsuk, Ross Bruce S, Du Jinfa, Otto Michael J and Sofia Michael J. Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. : Antiviral research. 20111109.